Non-Squamous Non-Small Cell Lung Cancer Completed Phase 4 Trials for Bevacizumab (DB00112)

Also known as: Non-squamous Non-small Cell Lung Cancer

IndicationStatusPhase
DBCOND0036730 (Non-Squamous Non-Small Cell Lung Cancer)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00451906A Study of Avastin (Bevacizumab) in Combination With Platinum-Containing Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer.Treatment